Skip to main content
. 2018 May 24;33(1):978–988. doi: 10.1080/14756366.2018.1474212

Table 3.

The effect of compounds on indomethacin-induced gastric mucosal lesions (mean ± SE).

Treatment Dose (mg/kg, i.p.) Ulcer index
Control (indomethacin) 30 35.66 ± 1.05
Ranitidine (standard) 50 8.50 ± 0.56***
3 12.5 29.83 ± 1.66*
3 25 20.50 ± 1.52***
3 50 12.66 ± 1.28***
8 12.5 33.00 ± 1.52
8 25 29.50 ± 1.58*
8 50 28.66 ± 1.45**
11 12.5 33.00 ± 1.03
11 25 30.66 ± 1.28*
11 50 28.33 ± 1.78**
15 12.5 26.33 ± 1.30***
15 25 21.50 ± 1.33***
15 50 14.50 ± 1.64***

Six rats were used in each group.

*

p < .05,

**

p < .01,

***

p < .001 vs. control (indomethacin only) group, Student’s t-test.